Literature DB >> 24479526

IL-33 stimulates CXCL8/IL-8 secretion in goblet cells but not normally differentiated airway cells.

T Tanabe1, T Shimokawaji, S Kanoh, B K Rubin.   

Abstract

BACKGROUND: IL-13, a helper T cell type 2 (Th2) cytokine, transforms cultured airway epithelial cells to goblet cells, and this is not inhibited by corticosteroids. IL-33 stimulates Th2 cytokines and is highly expressed in airways of persons with asthma. The effect of IL-33 on goblet cell differentiation and cytokine secretion has not been described.
OBJECTIVE: We examined the effect of IL-33 on CXCL8/IL-8 secretion from goblet or normally differentiated human bronchial epithelial (NHBE) cells and signalling pathways associated with IL-33 activation in these cells.
METHODS: Normal human bronchial epithelial cells were grown to goblet or normally differentiated ciliated cell phenotype at air-liquid interface in the presence or absence of IL-13. After 14 days, differentiated cells were exposed to IL-33 for 24 h.
RESULTS: CXCL8/IL-8 secretion into the apical (air) side of the goblet cells was greater than from normally differentiated cells (P < 0.01), and IL-33 stimulated apical CXCL8/IL-8 release from goblet cells, but not from normally differentiated cells (P < 0.01). IL-33 increased ERK 1/2 phosphorylation in goblet cells (P < 0.05), and PD98059, a MAPK/ERK kinase inhibitor, attenuated IL-33-stimulated CXCL8/IL-8 secretion from goblet cells (P < 0.001). IL-13 induced ST2 mRNA (P < 0.02) and membrane-bound ST2 protein expression on the apical side surface of goblet cells compared with normally differentiated cells, and neutralization with anti-ST2R antibody attenuated IL-33-induced apical CXCL8/IL-8 secretion from goblet cells (P < 0.02). CONCLUSIONS AND CLINICAL RELEVANCE: Goblet cells secrete CXCL8/IL-8, and this is increased by IL-33 through ST2R-ERK pathway, suggesting a mechanism for enhanced airway inflammation in the asthmatic airway with goblet cell metaplasia.
© 2014 John Wiley & Sons Ltd.

Entities:  

Keywords:  IL-13; Th2 cytokine; airway; asthma; goblet cell hyperplasia; mucin; normal human bronchial epithelial cell

Mesh:

Substances:

Year:  2014        PMID: 24479526      PMCID: PMC3982145          DOI: 10.1111/cea.12283

Source DB:  PubMed          Journal:  Clin Exp Allergy        ISSN: 0954-7894            Impact factor:   5.018


  61 in total

1.  A 3-D well-differentiated model of pediatric bronchial epithelium demonstrates unstimulated morphological differences between asthmatic and nonasthmatic cells.

Authors:  Jeremy Parker; Severine Sarlang; Surendran Thavagnanam; Grace Williamson; Dara O'donoghue; Remi Villenave; Ultan Power; Michael Shields; Liam Heaney; Grzegorz Skibinski
Journal:  Pediatr Res       Date:  2010-01       Impact factor: 3.756

Review 2.  TH17 cells in asthma and COPD.

Authors:  John F Alcorn; Christopher R Crowe; Jay K Kolls
Journal:  Annu Rev Physiol       Date:  2010       Impact factor: 19.318

3.  Resolution of allergic inflammation and airway hyperreactivity is dependent upon disruption of the T1/ST2-IL-33 pathway.

Authors:  Jennifer Kearley; Karen F Buckland; Sara A Mathie; Clare M Lloyd
Journal:  Am J Respir Crit Care Med       Date:  2009-01-29       Impact factor: 21.405

4.  Human basophils and eosinophils are the direct target leukocytes of the novel IL-1 family member IL-33.

Authors:  Tatjana Pecaric-Petkovic; Svetlana A Didichenko; Sacha Kaempfer; Nicole Spiegl; Clemens A Dahinden
Journal:  Blood       Date:  2008-10-27       Impact factor: 22.113

5.  IL-33 amplifies the polarization of alternatively activated macrophages that contribute to airway inflammation.

Authors:  Mariola Kurowska-Stolarska; Bartosz Stolarski; Peter Kewin; Grace Murphy; Christopher J Corrigan; Sun Ying; Nick Pitman; Ananda Mirchandani; Batika Rana; Nico van Rooijen; Malcolm Shepherd; Charlie McSharry; Iain B McInnes; Damo Xu; Foo Y Liew
Journal:  J Immunol       Date:  2009-10-19       Impact factor: 5.422

6.  Anti-IL-33 antibody treatment inhibits airway inflammation in a murine model of allergic asthma.

Authors:  Xiaojin Liu; Mingcai Li; Yan Wu; Yanchun Zhou; Liangming Zeng; Tian Huang
Journal:  Biochem Biophys Res Commun       Date:  2009-06-07       Impact factor: 3.575

7.  The cytokine interleukin-33 mediates anaphylactic shock.

Authors:  Peter N Pushparaj; Hwee Kee Tay; Shiau Chen H'ng; Nick Pitman; Damo Xu; Andrew McKenzie; Foo Y Liew; Alirio J Melendez
Journal:  Proc Natl Acad Sci U S A       Date:  2009-06-08       Impact factor: 11.205

Review 8.  The mechanism of mucus production in bronchial asthma.

Authors:  K Izuhara; S Ohta; H Shiraishi; S Suzuki; K Taniguchi; S Toda; T Tanabe; M Yasuo; K Kubo; T Hoshino; H Aizawa
Journal:  Curr Med Chem       Date:  2009       Impact factor: 4.530

9.  CD34+ hemopoietic progenitor cells are potent effectors of allergic inflammation.

Authors:  Zoulfia Allakhverdi; Michael R Comeau; Dirk E Smith; Dean Toy; Leandra Mfuna Endam; Martin Desrosiers; Yong-Jun Liu; Karen J Howie; Judah A Denburg; Gail M Gauvreau; Guy Delespesse
Journal:  J Allergy Clin Immunol       Date:  2008-12-06       Impact factor: 10.793

10.  Increased expression of IL-33 in severe asthma: evidence of expression by airway smooth muscle cells.

Authors:  David Préfontaine; Stéphane Lajoie-Kadoch; Susan Foley; Séverine Audusseau; Ron Olivenstein; Andrew J Halayko; Catherine Lemière; James G Martin; Qutayba Hamid
Journal:  J Immunol       Date:  2009-10-15       Impact factor: 5.422

View more
  18 in total

1.  Tollip Inhibits ST2 Signaling in Airway Epithelial Cells Exposed to Type 2 Cytokines and Rhinovirus.

Authors:  Azzeddine Dakhama; Reem Al Mubarak; Nicole Pavelka; Dennis Voelker; Max Seibold; Julie G Ledford; Monica Kraft; Liwu Li; Hong Wei Chu
Journal:  J Innate Immun       Date:  2019-03-29       Impact factor: 7.349

Review 2.  IL-33: biological properties, functions, and roles in airway disease.

Authors:  Li Yin Drake; Hirohito Kita
Journal:  Immunol Rev       Date:  2017-07       Impact factor: 12.988

3.  Secretory phospholipases A2 are secreted from ciliated cells and increase mucin and eicosanoid secretion from goblet cells.

Authors:  Tsuyoshi Tanabe; Tadasuke Shimokawaji; Soichiro Kanoh; Bruce K Rubin
Journal:  Chest       Date:  2015-06       Impact factor: 9.410

Review 4.  Conjunctival Goblet Cell Function: Effect of Contact Lens Wear and Cytokines.

Authors:  Laura García-Posadas; Laura Contreras-Ruiz; Laura Soriano-Romaní; Darlene A Dartt; Yolanda Diebold
Journal:  Eye Contact Lens       Date:  2016-03       Impact factor: 2.018

5.  IL-33 Promotes Gastric Cancer Cell Invasion and Migration Via ST2-ERK1/2 Pathway.

Authors:  Xi-Xiang Yu; Zhe Hu; Xian Shen; Li-Yang Dong; Wei-Zhong Zhou; Wen-Hao Hu
Journal:  Dig Dis Sci       Date:  2015-02-06       Impact factor: 3.199

6.  Interleukin 1 Receptor-Like 1 (IL1RL1) Promotes Airway Bacterial and Viral Infection and Inflammation.

Authors:  Niccolette Schaunaman; Amelia Sanchez; Kris Genelyn Dimasuay; Nicole Pavelka; Mari Numata; Rafeul Alam; Richard J Martin; Hong Wei Chu
Journal:  Infect Immun       Date:  2019-06-20       Impact factor: 3.441

7.  Lactobacillus paracasei strain 06TCa19 suppresses inflammatory chemokine induced by Helicobacter pylori in human gastric epithelial cells.

Authors:  Shiro Takeda; Keiji Igoshi; Chuluunbat Tsend-Ayush; Tsendesuren Oyunsuren; Ryoichi Sakata; Yasuhiro Koga; Yuo Arima; Masahiko Takeshita
Journal:  Hum Cell       Date:  2017-04-22       Impact factor: 4.174

Review 8.  Key mediators in the immunopathogenesis of allergic asthma.

Authors:  Sannette Hall; Devendra K Agrawal
Journal:  Int Immunopharmacol       Date:  2014-06-13       Impact factor: 4.932

Review 9.  Goblet cells: multifaceted players in immunity at mucosal surfaces.

Authors:  Kathryn A Knoop; Rodney D Newberry
Journal:  Mucosal Immunol       Date:  2018-06-04       Impact factor: 7.313

10.  Bronchial lesions of mouse model of asthma are preceded by immune complex vasculitis and induced bronchial associated lymphoid tissue (iBALT).

Authors:  Ian C Guest; Stewart Sell
Journal:  Lab Invest       Date:  2015-06-01       Impact factor: 5.662

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.